Highland Capital Management, LLC Gilead Sciences, Inc. Transaction History

Highland Capital Management, LLC

$1.73 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$57.92 - $72.58 $183,085 - $229,425	-3,161 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$64.88 - $73.64 $96,736 - $109,797	-1,491 Reduced 32.05%	3,161 $230,000
Q3 2021 Oct 25, 2021	SELL	$67.69 - $73.03 $23,962 - $25,852	-354 Reduced 7.07%	4,652 $325,000
Q2 2021 Jul 30, 2021	SELL	$63.47 - $69.35 $4,760 - $5,201	-75 Reduced 1.48%	5,006 $345,000
Q1 2021 Apr 27, 2021	SELL	$60.0 - $68.46 $10,740 - $12,254	-179 Reduced 3.4%	5,081 $328,000

Q4 2020 Jan 21, 2021	SELL	$56.65 - $64.55 $67,186 - $76,556	-1,186 Reduced 18.4%	5,260 $306,000
Q3 2020 Oct 16, 2020	SELL	$62.1 - $78.08 $543,933 - $683,902	-8,759 Reduced 57.61%	6,446 $407,000
Q2 2020 Jul 22, 2020	SELL	$72.34 - $84.0 $4,991 - $5,796	-69 Reduced 0.45%	15,205 $1.17 Million
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $154,946 - $198,464	-2,474 Reduced 13.94%	15,274 $1.14 Million
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $240,133 - $264,138	-3,897 Reduced 18.0%	17,748 $1.15 Million
Q3 2019 Nov 20, 2019	SELL	$62.51 - $69.0 $8,126 - $8,970	-130 Reduced 0.6%	21,645 $1.37 Million
Q2 2019 Jul 29, 2019	SELL	$61.87 - $69.38 $849,970 - $953,142	-13,738 Reduced 38.68%	21,775 $1.47 Million
Q1 2019 Apr 18, 2019	BUY	$62.53 - $70.05 $12,255 - $13,729	196 Added 0.55%	35,513 $2.31 Million
Q4 2018 Jan 16, 2019	SELL	$60.54 - $79.0 $184,828 - $241,187	-3,053 Reduced 7.96%	35,317 $2.21 Million
Q3 2018 Oct 17, 2018	SELL	$71.28 - $78.92 $28,298 - $31,331	-397 Reduced 1.02%	38,370 $2.96 Million
Q2 2018 Jul 18, 2018	SELL	$64.88 - $75.68 $40,030 - $46,694	-617 Reduced 1.57%	38,767 $2.75 Million
Q1 2018 Apr 16, 2018	BUY	$72.84 - $88.8 $199,945 - $243,756	2,745 Added 7.49%	39,384 $2.97 Million
Q4 2017 Jan 26, 2018	SELL	$71.15 - $83.52 $123,302 - $144,740	-1,733 Reduced 4.52%	36,639 $2.63 Million
Q3 2017 Oct 10, 2017	BUY	$72.11 - $85.47 $2.77 Million - $3.28 Million	38,372	38,372 $3.11 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

Black Rock Inc. New York, NY

123M
Shares

$8.17 Billion
0.21% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$7.65 Billion
0.17% of portfolio
Capital World Investors Los Angeles, CA

84.5M
Shares

$5.64 Billion
1.06% of portfolio
Capital Research Global Investors Los Angeles, CA

61.2M
Shares

$4.08 Billion
1.05% of portfolio
State Street Corp Boston, MA

57.7M
Shares

$3.85 Billion
0.19% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.

Account